Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
about
Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unitPharmacokinetic Changes and Dosing Modification of Aminoglycosides in Critically Ill Obese Patients: A Literature ReviewApplications of flow cytometry to clinical microbiology.Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceTherapeutic drug monitoring of amikacin in septic patients.Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatmentNonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children.A multicenter evaluation of gentamicin therapy in the neonatal intensive care unit.Pharmacodynamics of antiinfective therapy: taking what we know to the patient's bedside.Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.Accuracy of empiric gentamicin dosing guidelines in neonatesRisk factors for toxicity in elderly patients given aminoglycosides once daily.Once-daily aminoglycosides in patients with neutropenic fever.Clinical issues surrounding once-daily aminoglycoside dosing in children.Tobramycin exposure from active calcium sulfate bone graft substituteVersatility of aminoglycosides and prospects for their future.Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: Antibiotic' nomogram and the SeBA-GEN and DoseCalc software programsOptimization of antibiotic dosing schedules in the light of increasing antibiotic resistance.Continuous beta-lactam infusion in critically ill patients: the clinical evidenceProviding guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.Pharmacodynamics of antimicrobials: treatment optimisation.Treatment of Pseudomonas aeruginosa infection in critically ill patients.Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature.Atorvastatin for Prevention of Amikacin-induced Electrolytes Imbalances; a Randomized Clinical Trial.Pharmacokinetic and pharmacodynamic properties of meropenem.High-Dose, Extended-Interval Gentamicin and Tobramycin for Pediatric Inpatients: A Survey of Canadian Hospital PharmacistsPharmacist-driven aminoglycoside quality improvement program.Pharmacotherapy of diabetic foot osteomyelitis.Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.Aminoglycoside therapy in infectious diseases.Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.Aminoglycoside toxicity in neonates: something to worry about?Aminoglycosides use in patients over 75 years old.Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature.Aminoglycoside-induced nephrotoxicity.
P2860
Q28950856-E9126681-D28D-4B4E-BF99-79B0E890E0D0Q29248398-E5C38C64-0B82-400F-A226-AEA98FA0D04CQ33555394-EFD12E67-23A4-46F7-85D0-07BEE256CC5CQ33640559-39838255-6ABA-4C2B-B8C9-F13723230AFCQ33754166-D1F01E49-4BCC-4845-AA64-E21642F6D85CQ33824149-40926213-E93B-4E73-B103-3CE7B5559729Q34106577-C499C742-35AE-43AB-8BF8-6CECB6165DFFQ34146978-71D79319-CFB4-4F65-A439-4CBD400359D0Q34443415-ADC1A6B4-E3B7-4FCD-A6F9-5C35ED7FEF7FQ34476089-D38F0CD9-244B-44C3-B563-C46D2C1EC0ABQ34589031-E1A244F3-7748-4376-B064-8E78A524416EQ34752229-8F93217E-1967-4A91-90D2-B21E871787D4Q34985783-CFAAC8CA-3B9B-4ADB-86BC-16DFC18213B3Q35043373-40807A1F-1FC8-40DD-9ACB-2D1A00FE06D0Q35110405-8A22E453-B180-4CD6-9C0D-368B8539E46CQ35176271-8BC8918E-4B72-495B-A1B8-3FBCA12412BAQ35262273-8ED188AB-DD01-4645-A0D1-BD531E444A7FQ35616211-6DD3E55D-0D75-4A25-9440-38B1AAD09577Q35745888-69D9D571-CA33-4CEA-8599-06EF82432A01Q35806154-2DD87AB3-25A7-464F-82F6-6E9CF9551B6AQ35826231-F9C75C96-A35A-49EA-A4AC-A3C856D13C68Q35826457-80FB1D12-E5DF-45F5-AE42-001D60AE6C51Q35917371-E54D3C72-6189-4321-9DA4-3CFA5324A295Q36329228-9D394982-B58C-4C8A-93EC-D71083C42CCAQ36366980-F0412704-AB24-4E88-ABDA-76F902ADDC77Q36544935-2EEEF3A6-0433-4CBA-90F8-85C1327355D0Q36607415-80545B96-92A7-4448-92A7-609EBDC7D3F1Q36739797-4145646F-6F30-4FA4-9150-3D2EE60E20F2Q37246422-1ADECD6B-370B-40D2-BC5E-5AF9BB1046D5Q37247125-E8C77788-8C79-4E0F-9ADE-EDE7AE026B56Q37376795-F5216303-605F-4552-9AD0-7D7EE4BE065AQ37417871-24455437-BEA7-488E-B403-006B894D3A15Q37642761-69BFE7F6-0B59-4051-ACBB-025399A1F57AQ37661512-1AA44349-EA96-4ABC-83A4-BE6F505B91CAQ38112810-2FD33CC0-74FC-4D0A-B67E-678667376E76Q38147851-619D0DF4-84CC-42EE-ADB2-707D779BF3FAQ38181171-54E86F78-B167-4921-B67A-C9503DF55726Q38192961-E96482DA-081E-4A02-8448-1A5776CD420DQ38239999-416CC814-89C0-4672-B7C1-F0F8E6800AA0Q38246945-AC1E647D-979A-4935-AC57-4813B1238F9B
P2860
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
@en
type
label
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
@en
prefLabel
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
@en
P2093
P356
P1476
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
@en
P2093
Belliveau PP
Freeman CD
Nicolau DP
Nightingale CH
P304
P356
10.1093/JAC/39.6.677
P407
P577
1997-06-01T00:00:00Z